{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T13:46:16Z","timestamp":1787319976952,"version":"build-2736575974"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/j.pharep.2014.08.016","type":"journal-article","created":{"date-parts":[[2014,8,27]],"date-time":"2014-08-27T14:46:08Z","timestamp":1409150768000},"page":"160-165","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"title":["Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system"],"prefix":"10.1007","volume":"67","author":[{"given":"Karolina","family":"Pytka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Rapacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Zygmunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Olczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Waszkielewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Sapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Filipek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2014.08.016_bib0005","first-page":"300","article-title":"Do we need new therapeutic strategies for depression?","volume":"23","author":"Mihaljevi\u0107-Pele\u0161","year":"2011","journal-title":"Psychiatr Danub"},{"key":"10.1016\/j.pharep.2014.08.016_bib0010","first-page":"461","article-title":"Central activity of new xanthone derivatives with chiral center in some pharmacological tests in mice","volume":"55","author":"Jastrzebska-Wiesek","year":"2003","journal-title":"Pol J Pharmacol"},{"key":"10.1016\/j.pharep.2014.08.016_bib0015","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.bmc.2012.11.014","article-title":"Synthesis and preliminary evaluation of pharmacological properties of some piperazine derivatives of xanthone","volume":"21","author":"Szkaradek","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.pharep.2014.08.016_bib0020","first-page":"735","article-title":"Antiarrhythmic, hypotensive and \u03b11-adrenolytic properties of new 2-methoxyphenylpiperazine derivatives of xanthone","volume":"15","author":"Rapacz","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2014.08.016_bib0025","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.phymed.2009.07.002","article-title":"Effect of xanthone from Kielmeyera coriacea stems on serotonergic neurons of the median raphe nucleus","volume":"17","author":"Sela","year":"2010","journal-title":"Phytomedicine"},{"key":"10.1016\/j.pharep.2014.08.016_bib0030","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.pbb.2005.03.019","article-title":"Neuropharmacological evaluation of diethylether extract and xanthones of Gentiana kochiana","volume":"81","author":"Tomi\u0107","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2014.08.016_bib0035","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1381-1177(00)00112-0","article-title":"Xanthone derivatives as inhibitors for monoamine oxidase","volume":"10","author":"Ohishi","year":"2000","journal-title":"J Mol Catal B: Enzym"},{"key":"10.1016\/j.pharep.2014.08.016_bib0040","doi-asserted-by":"crossref","first-page":"4419","DOI":"10.1016\/j.bmcl.2013.05.062","article-title":"Synthesis and evaluation of pharmacological properties of some new xanthone derivatives with piperazine moiety","volume":"23","author":"Waszkielewicz","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2014.08.016_bib0045","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2014.08.016_bib0050","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.pnpbp.2008.12.011","article-title":"The involvement of serotonergic system in the antidepressant effect of zinc in the forced swim test","volume":"33","author":"Szewczyk","year":"2009","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2014.08.016_bib0055","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1007\/s00210-013-0847-2","article-title":"Evaluation of antinociceptive and antioxidant properties of 3-[4-(3-trifluoromethyl-phenyl)-piperazin-1-yl]-dihydrofuran-2-one in mice","volume":"386","author":"Sa\u0142at","year":"2013","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharep.2014.08.016_bib0060","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0022-3565(25)03549-9","article-title":"A simplified method of evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2014.08.016_bib0065","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00213-004-2048-7","article-title":"Forced swimming test in mice: a review of antidepressant activity","volume":"177","author":"Petit-Demouliere","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2014.08.016_bib0070","first-page":"464","article-title":"Influence of serotonin 5-HT(7) receptor blockade on the behavioral and neurochemical effects of imipramine in rats","volume":"60","author":"Weso\u0142owska","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2014.08.016_bib0075","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/j.neuropharm.2006.04.017","article-title":"Effect of the selective 5-HT7 receptor antagonist SB 269970 in animal models of anxiety and depression","volume":"51","author":"Weso\u0142owska","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharep.2014.08.016_bib0080","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/BF00176837","article-title":"Is the forced swimming test a suitable model for revealing antidepressant activity?","volume":"94","author":"Borsini","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pharep.2014.08.016_bib0085","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1016\/j.pnpbp.2008.09.006","article-title":"Interaction of zinc with antidepressants in the tail suspension test","volume":"32","author":"Cunha","year":"2008","journal-title":"Prog Neuro-psychopharmacol Biol"},{"key":"10.1016\/j.pharep.2014.08.016_bib0090","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.bmcl.2010.01.093","article-title":"Arylpiperazine-containing pyrrole 3-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant","volume":"20","author":"Kang","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2014.08.016_bib0095","doi-asserted-by":"crossref","first-page":"6439","DOI":"10.1016\/j.bmcl.2010.09.081","article-title":"Arylpiperazine-containing pyrimidine 4-carboxamide derivatives targeting serotonin 5-HT2A, 5-HT2C, and the serotonin transporter as a potential antidepressant","volume":"20","author":"Kim","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2014.08.016_bib0100","doi-asserted-by":"crossref","DOI":"10.1007\/s12272-013-0119-1","article-title":"Synthesis of new 1-phenyl-2-(4-substituted-piperazin-1-yl)-propanol derivatives and evaluation of their antidepressant-like effects","author":"Demir \u00d6zkay","year":"2013","journal-title":"Arch Pharm Res"},{"key":"10.1016\/j.pharep.2014.08.016_bib0105","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1016\/j.bmcl.2012.09.089","article-title":"Synthesis, characterization, antidepressant and antioxidant activity of novel piperamides bearing piperidine and piperazine analogues","volume":"22","author":"Prashanth","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.pharep.2014.08.016_bib0110","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.pbb.2009.09.018","article-title":"A novel 5-HT2A receptor antagonist exhibits antidepressant-like effects in a battery of rodent behavioural assays: approaching early-onset antidepressants","volume":"94","author":"Pandey","year":"2010","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2014.08.016_bib0115","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0022-3565(25)27497-3","article-title":"p-Chlorophenylalanine: a specific depletor of brain serotonin","volume":"154","author":"Koe","year":"1966","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.pharep.2014.08.016_bib0120","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/2041318a0","article-title":"Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds","volume":"204","author":"G\u0142owi\u0144ski","year":"1964","journal-title":"Nature"},{"key":"10.1016\/j.pharep.2014.08.016_bib0125","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1176\/ajp.122.5.509","article-title":"The catecholamine hypothesis of affective disorders: a review of supporting evidence","volume":"122","author":"Schildkraut","year":"1965","journal-title":"Am J Psychiatry"},{"issue":"4","key":"10.1016\/j.pharep.2014.08.016_bib0130","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.pharep.2014.02.014","article-title":"Evaluation of anticonvulsant activity of novel pyrrolidin-2-one derivatives","volume":"66","author":"Sapa","year":"2014","journal-title":"Pharmacol Rep"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114014002771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:35:42Z","timestamp":1752611742000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2014.08.016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S1734114014002771"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2014.08.016","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antidepressant-like activity of a new piperazine derivative of xanthone in the forced swim test in mice: The involvement of serotonergic system","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2014.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier Urban & Partner Sp. z o.o. All rights reserved.","name":"copyright","label":"Copyright"}]}}